Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD), for which there are unmet needs surrounding its management. Four posters presented at international congresses in 2019 and 2020 investigated the management of SHPT, including the efficacy and safety of current and future treatments.
Latest articles
All articles![EMJ Nephrology 8 [Supplement 3] 2020 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2020/10/EMJ-Nephrology-8-Supplement-3-2020-Feature-Image-940x572.jpg)
23
Jul
Pharmacokinetics of Ceftriaxone During Prolonged Intermittent Renal Replacement Therapy in a Patient with Child–Pugh B Cirrhosis and Ascites
Prolonged intermittent renal replacement therapy (PIRRT) is emerging as an alternative to continuous renal replacement therapy as renal support for the critically ill.